ID   SAS-L1
AC   CVCL_R860
DR   Wikidata; Q54952125
RX   PubMed=8521415;
RX   PubMed=9379426;
CC   Population: Japanese.
CC   Doubling time: 31.4 +- 2.2 hours (PubMed=9379426).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1675 ! SAS
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=8521415;
RA   Muramatsu H., Kogawa K., Tanaka M., Okumura K., Nishihori Y.,
RA   Koike K., Kuga T., Niitsu Y.;
RT   "Superoxide dismutase in SAS human tongue carcinoma cell line is a
RT   factor defining invasiveness and cell motility.";
RL   Cancer Res. 55:6210-6214(1995).
//
RX   PubMed=9379426; DOI=10.1111/j.1600-0714.1997.tb00232.x;
RA   Abiko Y., Okumura K., Ohuchi T., Konishi T., Kanazawa M., Kaku T.;
RT   "Basaloid-squamous cell carcinoma of the floor of the mouth:
RT   characterization of a cell line.";
RL   J. Oral Pathol. Med. 26:367-370(1997).
//